Non–AIDS-Defining Cancers

  • Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 12/12/16 (What's New)

Summary

  • Most large-scale studies report significantly lower prostate cancer rates in HIV-infected population vs general population[Frisch 2001; Grulich 2007; Althoff 2013]
  • Risk factors include increased age, black race, familial history of prostate cancer, androgen use, and possibly prostatitis[Mani 2013]
  • HIV-infected patients with prostate cancer and well-controlled HIV viremia should be managed similarly to HIV-negative patients

Action required

Keywords: Cancer

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.